A19 D-4 Public Disclosure and Publication of Vaccine Pricing.docx

DOCX document 17 KB Posted

Attached to
FY27-28 Adult Flu Vaccines
Solicitation number
75D30126R73517
Issued by

About this file

This is an attachment detailing public disclosure and publication requirements for vaccine pricing under a federal contract solicitation. The document establishes that by submitting an offer in response to the FY27-28 Adult Flu Vaccines solicitation, offerors acknowledge and agree that the Centers for Disease Control and Prevention (CDC) may publicly disclose pricing information for vaccines supplied under any resulting contract. The disclosure may include per-dose or per-unit vaccine pricing, commercial pricing provided by the manufacturer, vaccine product name and manufacturer information, National Drug Code (NDC) numbers, and the associated contract number. Offerors expressly authorize such public disclosure as a mandatory condition of contract award and agree that CDC's publication of this pricing information shall not violate any confidentiality, nondisclosure, or proprietary information restrictions. This authorization survives contract execution and remains binding on the contractor throughout the duration of contract performance, with submission of an offer constituting automatic acceptance of these terms.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Attachment D-4

Public Disclosure and Publication of Vaccine Pricing

By submitting an offer in response to this solicitation, Offeror acknowledges and agrees that, if awarded a contract, the Centers for Disease Control and Prevention (CDC) may publish, disclose, or otherwise make publicly available, on its official website or through other public communications, the pricing information for vaccines supplied by Offeror under any resulting contract, to include:

(a) Per-dose or per-unit vaccine pricing;

(b) Commercial pricing, as provided by the manufacturer;

(c) Vaccine product name, manufacturer, and associated National Drug Code (NDC); and

(d) Contract number.

Offeror expressly authorizes such disclosure as a condition of any resulting award and agrees that CDC's publication of this pricing information, consistent with the terms of any resulting contract, shall not constitute a violation of any confidentiality, nondisclosure, proprietary-information, or similar restriction applicable to Offeror or to the information furnished under any resulting contract. This authorization survives execution of the contract and remains binding on the Contractor for the duration of contract performance.

Offeror further acknowledges that submission of an offer in response to this solicitation constitutes acceptance of this term.

Contractor Signature/Date

File details come from the government source that posted it. Updated .